105 related articles for article (PubMed ID: 11576231)
1. Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab')2: pharmacokinetics, tissue distribution, and tumor imaging.
Buist MR; Kenemans P; Vermorken JB; Golding RP; Burger CW; Den Hollander W; Van Kamp GJ; Van Lingen A; Teule GJ; Baak JP; Roos JC
Int J Gynecol Cancer; 1992 Jan; 2(1):23-34. PubMed ID: 11576231
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Schijf CP; Strijk SP; Poels LG; van Hoesel RG; Corstens FH
J Nucl Med; 1990 Nov; 31(11):1802-10. PubMed ID: 2230993
[TBL] [Abstract][Full Text] [Related]
3. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
6. Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
Tibben JG; Thomas CM; Massuger LF; Segers MF; Schijf CP; Corstens FH; Boerman OC
Nucl Med Commun; 1995 Oct; 16(10):853-9. PubMed ID: 8570116
[TBL] [Abstract][Full Text] [Related]
7. Specific and nonspecific immunoassays to detect HAMA after administration of indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody to patients with ovarian cancer.
Massuger LF; Thomas CM; Segers MF; Corstens FH; Verheijen RH; Kenemans P; Poels LG
J Nucl Med; 1992 Nov; 33(11):1958-63. PubMed ID: 1432156
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and tissue distribution of the radiolabeled chimeric monoclonal antibody MOv18 IgG and F(ab')2 fragments in ovarian carcinoma patients.
Buist MR; Kenemans P; den Hollander W; Vermorken JB; Molthoff CJ; Burger CW; Helmerhorst TJ; Baak JP; Roos JC
Cancer Res; 1993 Nov; 53(22):5413-8. PubMed ID: 8221680
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and biodistribution in relation to tumour detection with 111In-labelled OV-TL 3 F(ab')2 in patients with ovarian cancer.
Massuger LF; Claessens RA; Kenemans P; Verheijen RH; Boerman OC; Meeuwis AP; Schijf CP; Buijs WC; Hanselaar TG; Corstens FH
Nucl Med Commun; 1991 Jul; 12(7):593-609. PubMed ID: 1923151
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Wilhelm AJ; van Lingen A; Snow GB; Dongen GA
Clin Cancer Res; 1995 Mar; 1(3):277-86. PubMed ID: 9815983
[TBL] [Abstract][Full Text] [Related]
13. Localization of radiolabelled F(ab')2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts.
Moseley KR; Battaile A; Knapp RC; Haisma HJ
Int J Cancer; 1988 Sep; 42(3):368-72. PubMed ID: 3417365
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
[TBL] [Abstract][Full Text] [Related]
15. Development and preclinical studies of
Lam K; Chan C; Reilly RM
MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
[TBL] [Abstract][Full Text] [Related]
16. Tumor uptake of intravenously administered radiolabeled antibodies in ovarian carcinoma patients in relation to antigen expression and other tumor characteristics.
Buist MR; Kenemans P; Molthoff CF; Roos JC; Den Hollander W; Brinkhuis M; Baak JP
Int J Cancer; 1995 Apr; 64(2):92-8. PubMed ID: 7615359
[TBL] [Abstract][Full Text] [Related]
17. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
[TBL] [Abstract][Full Text] [Related]
18. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
Buijs WC; Massuger LF; Claessens RA; Kenemans P; Corstens FH
J Nucl Med; 1992 Jun; 33(6):1113-20. PubMed ID: 1597725
[TBL] [Abstract][Full Text] [Related]
20. Optimization of IGF-1R SPECT/CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507.
Heskamp S; van Laarhoven HW; Molkenboer-Kuenen JD; Bouwman WH; van der Graaf WT; Oyen WJ; Boerman OC
Mol Pharm; 2012 Aug; 9(8):2314-21. PubMed ID: 22747077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
